FDA Issues Warning Letter to Accupack Midwest
September 25, 2024
September 25, 2024
WASHINGTON, Sept. 25 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Accupack Midwest Inc.:
* * *
To: Mr. Mark A. Proctor, President, Accupack Midwest, Inc., 1060 Meta Drive, Cincinnati, OH 45237, United States
Dear Mr. Proctor:
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, Accupack Midwest, Inc., FEI 1000122754, at 1060 Meta Drive, . . .
* * *
To: Mr. Mark A. Proctor, President, Accupack Midwest, Inc., 1060 Meta Drive, Cincinnati, OH 45237, United States
Dear Mr. Proctor:
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, Accupack Midwest, Inc., FEI 1000122754, at 1060 Meta Drive, . . .